Stockscreener 앱 받기
4.08
0.00%
0.00
시간 외 거래:
4.01
-0.07
-1.72%
전일 마감가:
$4.08
열려 있는:
$4.08
하루 거래량:
1,934
Relative Volume:
0.20
시가총액:
$150.45M
수익:
$7.80M
순이익/손실:
$-69.02M
주가수익비율:
-1.9054
EPS:
-2.1413
순현금흐름:
$-66.61M
1주 성능:
+0.00%
1개월 성능:
+14.30%
6개월 성능:
-29.04%
1년 성능:
+2.51%
1일 변동 폭
$4.08
$4.15
1주일 범위
$3.36
$4.15
52주 변동 폭
$3.36
$12.70
Molecular Partners Ag Adr Stock (MOLN) Company Profile
MOLN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MOLN
Molecular Partners Ag Adr
|
4.08 | 150.45M | 7.80M | -69.02M | -66.61M | -2.1413 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Molecular Partners Ag Adr Stock (MOLN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-30 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-08-29 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-05-25 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2022-04-27 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2021-07-13 | 개시 | Cowen | Outperform |
| 2021-07-12 | 재개 | SVB Leerink | Outperform |
모두보기
Molecular Partners Ag Adr 주식(MOLN)의 최신 뉴스
Now Is The Time To Build A Position In NanoVibronix Inc (NASDAQ:NAOV) - Marketing Sentinel
Can Contango ORE, Inc. (CTGO) Climb 163.28% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Here's Why Molecular Partners AG Sponsored ADR (MOLN) Could be Great Choice for a Bottom Fisher - Yahoo Finance
Musk's DOGE Exit Rumors & Weak Q1 Deliveries: How to Play Tesla Now - Yahoo Finance
Why Tractor Supply (TSCO) is a Top Momentum Stock for the Long-Term - Yahoo Finance
TD Cowen maintains Buy on Molecular Partners, target CHF15 - Investing.com India
Molecular Partners reports 2024 annual results - Investing.com India
Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024 - GlobeNewswire Inc.
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance
Here's Why Seagate (STX) is a Strong Momentum Stock - Yahoo Finance
Molecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M - TipRanks
Molecular Partners, Orano Med announce presentation of MP0712 data - TipRanks
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga
US stock market gainers for the last week of April 2022 - Nairametrics
Novartis to push forward with covid drug after positive results - Luxembourg Times
Wall Street Analysts See a 96% Upside in Molecular Partners AG Sponsored ADR (MOLN): Can the Stock Really Move This High? - Yahoo Finance
Citi Appointed as Depositary Bank for Molecular Partners AG’s ADR Programme - Business Wire
Molecular Partners Ag Adr (MOLN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):